Urethra Neoplasm — Trials

Urethra Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

85 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–13 of 13 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03866382	Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors	recruiting	Phase 2	314	National Cancer Institute (NCI)NIH	2	Sep 29, 2026	clinicaltrials
NCT05987241	Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study	recruiting	Phase 2 / Phase 3	992	National Cancer Institute (NCI)NIH	2	Sep 29, 2026	clinicaltrials
NCT04940299	Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma	active not recruiting	Phase 2	35	M.D. Anderson Cancer CenterOTHER	1	Sep 16, 2026	clinicaltrials

Data updated 13 hours agoSource updated Sep 29, 2026source: clinicaltrials